TL;DR
Current data regarding potential applications of polygenic risk scores for breast cancer may have use in unaffected and affected individuals and in those with and without germline pathogenic variants, as well as clinical and psychological impact.
AI-generated by Semantic Scholar
Authors
Kaitlin Demarest, Payal D. Shah
